Cravatex Ltd Fair Value
CRAVATEX · Services · Current price ₹422.8
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹428 | 6% ROE fading to 12% over ~3 yrs, on ₹463 book |
| Relative P/E | ₹685 | EPS × 36.2 peer-median P/E |
| Graham floor | ₹444 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is Cravatex Ltd undervalued?
DocStoX estimates the fair value of Cravatex Ltd at ₹503 per share, versus the current market price of ₹423. That puts the stock about +18.9% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is medium.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹428), Relative P/E (₹685), Graham floor (₹444). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹427 (bear) to ₹503 (base) to ₹685 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on Cravatex Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.